期刊文献+

清灵定眩汤治疗椎-基动脉供血不足眩晕临床分析 被引量:2

Clinical analysis of Qinglingdingxuan decoction in treating vertebro basilar ischemic vertigo
原文传递
导出
摘要 目的 探讨清灵定眩汤(QLDXD)治疗椎 基动脉供血不足眩晕(VBIV)的临床疗效。方法 对12 0例VBIV住院患者进行回顾性分析,其中91例为清灵定眩汤治疗组,2 9例为对照组(采用常规治疗) ,比较两组临床疗效及经颅多普勒(TCD)指标。结果 清灵定眩汤组临床疗效优于对照组(P <0 . 0 1) ,且能明显改善头痛、颈项不适、胸脘痞闷、恶心、痰多等伴随症状(P <0 .0 5 ) ,TCD指标较对照组也有明显改善(P <0 . 0 5 )。结论 清灵定眩汤对VBIV有确切的疗效,值得进一步研究和推广使用。 Objective To discuss the curative effect of Qinglingdingxuan Decoction(QLDXD) in treating vertebro basilar ischemic vertigo(VBIV).Methods 120 cases of VBIV patients were included in the retrospective clinical analysis.91 cases among these patients were in QLDXD treating group and the other 29 cases were in control group which received regular treatment.Clinical results and TCD indexes were compared in the two groups.Results Compared with control group,QLDXD group were significantly better in the clinical curative effect of vertigo treatment(P<0.01).Effect in the improvement of headache,malaise of neck,painful mass and tightly closed of thoracic and gastric cavity nausea and over excretion of sputum was better in treatment group and was significantly different from control group(P<0.05).TCD indexes were also significantly improved in QLDXD group(P<0.05).Conclusion There is an exact curative effect of QLDXD in treating VBIV and this is worthy of further study and popularization.
出处 《中国基层医药》 CAS 2005年第4期448-449,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 清灵定眩汤 椎-基动脉供血不足 眩晕 临床分析 中医药疗法 Qinglingdingxuan Decoction Vertebro basilar insufficiency Vertigo
  • 相关文献

参考文献4

二级参考文献15

  • 1曹冠柏.尼莫地平预防创伤性蛛网膜下腔出血后脑血管痉挛[J].中国药业,1997,6(7):20-20. 被引量:1
  • 2Caplan LR. Vertebrobasilar disease and thrombolytic treatment. Arch Neurol, 1998, 55(4): 450-451.
  • 3Caplan LR. Posterior Circulation Diseases: Clinical findings, Diagnosis and Management. Cambridge, Mass: Blackwell Science, 1996.544-568.
  • 4Caplan LR. Posterior circulation ischemia: then, now, and tomorrow. The Thomas Willis Lecture. Stroke, 2000, 31 (8): 2011-2023.
  • 5Caplan LR, Pessin MS, Mohr JP. Vertebrobasilar occlusive disease.In: Barnett HJM, Mohr JP, Stein BM, eds. Stroke: Pathophysiology,Diagnosis, and Management. 2nd ed. New York: Chruchill Livingston, 1992. 443-515.
  • 6Hutchinson EC, Yates PO. The cervical portion of the vertebral artery: a clinicopathological study. Brain, 1956,79: 319-331.
  • 7Wityk RJ, Chang HM, Rosengart A, et al. Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol, 1998, 55(4): 470-478.
  • 8Kasner SE, Hankins LL, Bratina P, et al. Magnetic resonance angiography demonstrates vascular healing of carotid and vertebral artery dissections. Stroke, 1997, 28(10): 1993-1997.
  • 9Barinagarrementeria F, Amaya LE , Cantu C . Causes and mechanisms of cerebellar infarction in young patients. Stroke, 1997, 28(12): 2400 -2404.
  • 10Koennecke HC, Mast H, Trocio SS, et al. Microemboli in patients with vertebrobasilar ischemia: association with vertebrobasilar and cardiac lesions. Stroke, 1997, 28(3): 593-596.

共引文献58

同被引文献19

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部